Teiko Hasegawa
Kyoto Prefectural University of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Teiko Hasegawa.
Anti-Cancer Drugs | 1993
Teiko Hasegawa; Hoyoku Nishino; Akio Iwashima
To analyze the inhibitory effects of isothiocyanates on the growth of human cancer cells, the effects of these compounds on the cell cycle progression of HeLa cells were studied by flow cytometry. The accumulation of cells at G2/M phase was observed at 16 h after treatment with 10 microM allyl isothiocyanate, 2.5 microM benzyl or phenethyl isothiocyanate, at which concentrations the cell growth was inhibited to 41-79% of control. These results suggest that isothiocyanates delay the cell cycle progression of HeLa cells, leading to inhibition of cell growth.
Cancer Letters | 1990
J. Takayasu; Reiko Tanaka; Shunyo Matsunaga; Hisao Ueyama; Harukuni Tokuda; Teiko Hasegawa; Atsuko Nishino; Hoyoku Nishino; Akio Iwashima
Abiesenonic acid methyl ester (AVB-I acid methyl ester), a triterpenoid compound prepared from abieslactone, suppressed tumor promoter-induced phenomena in vitro and in vivo; i.e., AVB-I acid methyl ester inhibited 12-o-tetradecanoylphorbol-13-acetate (TPA)-stimulated 32Pi-incorporation into phospholipids of cultured cells and the promoting action of TPA on skin tumor formation in mice initiated with 7,12-dimethylbenz[a]anthracene.
Archive | 1992
Hoyoku Nishino; Michiaki Murakoshi; Hirokazu Kitana; Ryozo Iwasaki; Yoshito Tanaka; Miyuki Tsushima; Takao Matsuno; Hidetoshi Okabe; Junichi Okuzumi; Teiko Hasegawa; Junko Takayasu; Yoshiko Satomi; Harukuni Tokuda; Atsuko Nishino; Akio Iwashima
Carotenoids are known to inactivate certain reactive oxygen species, such as singlet oxygen. Since antioxidants have been suggested to be one of the promising agents for cancer control, it is worthwhile to evaluate the anti-cancer potency of these carotenoids.
FEBS Letters | 1984
Kiyofumi Yamanishi; Teiko Hasegawa; Akio Iwashima
The effects of vanadate on intracellular Ca2+ sequestration and hexose transport were studied in Swiss 3T3 cells. Vanadate inhibited ATP‐dependent Ca2+ uptake by saponin‐permeabilized Swiss 3T3 cells at 10−5 and 10−7M Ca2+ at which the Ca2+ uptake was sensitive and insensitive to oligomycin plus antimycin A, respectively. On the other hand, vanadate stimulated 2‐deoxy‐D‐glucose (2DG) uptake in a dose‐ and time‐dependent way. The stimulation of 2DG uptake by vanadate was inhibited by EGTA plus A23187 and the inhibition was reversed by Ca2+ restoration. These results suggest that an increase in cytosolic Ca2+ by inhibition of intracellular ATP‐dependent Ca2+ sequestration by vanadate results in the stimulation of hexose transport in Swiss 3T3 cells.
Cancer Research | 1988
Hoyoku Nishino; Atsuko Nishino; Junko Takayasu; Teiko Hasegawa; Akio Iwashima; Kazuhiro Hirabayashi; Susumu Iwata; Shoji Shibata
Cancer Research | 1992
Michiaki Murakoshi; Hoyoku Nishino; Yoshiko Satomi; Junko Takayasu; Teiko Hasegawa; Harukuni Tokuda; Akio Iwashima; Junichi Okuzumi; Hidetoshi Okabe; Hirokazu Kitano; Ryozo Iwasaki
Planta Medica | 1991
Toru Okuyama; M. Takata; Junko Takayasu; Teiko Hasegawa; Harukuni Tokuda; Atsuko Nishino; Hoyoku Nishino; Akio Iwashima
Planta Medica | 1991
Shoji Shibata; Hideo Inoue; Susumu Iwata; Rundi Ma; Lijian Yu; Hisao Ueyama; Junko Takayasu; Teiko Hasegawa; Harakuni Tokuda; Atsuko Nishino; Hoyoku Nishino; Akio Iwashima
Carcinogenesis | 1990
Hoyoku Nishino; Toro Okuyama; Mitsumasa Takata; Shoji Shibata; Harukuni Tokuda; Junko Takayasu; Teiko Hasegawa; Atsuko Nishino; Hisao Ueyama; Akio Iwashima
Cell Structure and Function | 1980
Hoyoku Nishino; Atsuko Nishino; Katsutoshi Fujita; Teiko Hasegawa; Akio Iwashima